 JERUSALEM, Aug. 3, 2021 PRNewswire -- Intec Parent, Inc. NASDAQ: NTEC Intec Parent or the Company, today announced that the pending and previously announced reverse merger the Decoy Merger with Decoy Biosystems, Inc. Decoy is currently expected to close after market hours today, Tuesday, August 3, 2021, subject to satisfaction or waiver of all closing conditions. Immediately following the closing, the combined company will be renamed Indaptus Therapeutics, Inc., and is expected to begin trading on The Nasdaq Capital Market under the new ticker symbol INDP upon the commencement of trading on Wednesday, August 4, 2021. 